• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有强大体外细胞毒性活性的手性铂(II)金属嵌入剂。

Chiral platinum(II) metallointercalators with potent in vitro cytotoxic activity.

作者信息

Fisher Dianne M, Bednarski Patrick J, Grünert Renate, Turner Peter, Fenton Ronald R, Aldrich-Wright Janice R

机构信息

Centre for Heavy Metals Research, School of Chemistry, The University of Sydney, NSW 2006, Australia.

出版信息

ChemMedChem. 2007 Apr;2(4):488-95. doi: 10.1002/cmdc.200600211.

DOI:10.1002/cmdc.200600211
PMID:17340669
Abstract

Four platinum(II) metallointercalating complexes of 1,10-phenanthroline (phen) with the chiral ancillary ligands trans-R,R- and trans-S,S-1,2-diaminocyclohexane (R,R- and S,S-dach, respectively), and N,N'-dimethyl-R,R- and N,N'-dimethyl-S,S-1,2-diaminocyclohexane (Me(2)-R,R-dach and Me(2)-S,S-dach, respectively) have been synthesised and characterised. The crystal structure of Pt(Me(2)-S,S-dach)(phen)(2)1.5 H(2)O (C(20)H(26)Cl(2)N(4)O(9.5)Pt) has been determined; orthorhombic, space group P2(1)2(1)2(1)(No. 19), a=23.194(8), b=25.131(9), c=8.522(3) A. In vitro cytotoxic assays (IC(50)) in the human bladder cancer cell line 5637 and in the murine leukemia L1210 cell line revealed that Pt(S,S-dach)(phen)(2) (0.091 and 0.13 microM, respectively) and Pt(R,R-dach)(phen)(2) (0.54 and 1.50 microM, respectively) were more cytotoxic than cisplatin (0.31 and 0.50 microM, respectively) and considerably more cytotoxic than their methylated counterparts, Pt(Me(2)-R,R-dach)(phen)(2) and Pt(Me(2)-S,S-dach)(phen)(2) (both>23 microM). Chiral discrimination for Pt(S,S-dach)(phen)(2) over its R,R-enantiomer was observed in all 13 cancer cell lines investigated. Moreover, Pt(S,S-dach)(phen)(2) was more active than cisplatin in all cell lines tested and shows only partial cross-resistance to cisplatin in two cisplatin resistant cell lines.

摘要

合成并表征了四种1,10 - 菲咯啉(phen)与手性辅助配体反式 - R,R - 和反式 - S,S - 1,2 - 二氨基环己烷(分别为R,R - 和S,S - dach)以及N,N'-二甲基 - R,R - 和N,N'-二甲基 - S,S - 1,2 - 二氨基环己烷(分别为Me(2)-R,R - dach和Me(2)-S,S - dach)形成的铂(II)金属插入配合物。已测定Pt(Me(2)-S,S - dach)(phen)(2)·1.5H(2)O(C(20)H(26)Cl(2)N(4)O(9.5)Pt)的晶体结构;正交晶系,空间群P2(1)2(1)2(1)(编号19),a = 23.194(8),b = 25.131(9),c = 8.522(3) Å。在人膀胱癌细胞系5637和小鼠白血病L1210细胞系中的体外细胞毒性测定(IC(50))表明,Pt(S,S - dach)(phen)(2)(分别为0.091和0.13 μM)和Pt(R,R - dach)(phen)(2)(分别为0.54和1.50 μM)比顺铂(分别为0.31和0.50 μM)细胞毒性更强,且比其甲基化对应物Pt(Me(2)-R,R - dach)(phen)(2)和Pt(Me(2)-S,S - dach)(phen)(2)(均>23 μM)细胞毒性大得多。在所有研究的13种癌细胞系中均观察到Pt(S,S - dach)(phen)(2)对其R,R - 对映体的手性识别。此外,Pt(S,S - dach)(phen)(2)在所有测试细胞系中比顺铂更具活性,并且在两种顺铂耐药细胞系中仅表现出对顺铂的部分交叉耐药性。

相似文献

1
Chiral platinum(II) metallointercalators with potent in vitro cytotoxic activity.具有强大体外细胞毒性活性的手性铂(II)金属嵌入剂。
ChemMedChem. 2007 Apr;2(4):488-95. doi: 10.1002/cmdc.200600211.
2
The effect of ancillary ligand chirality and phenanthroline functional group substitution on the cytotoxicity of platinum(II)-based metallointercalators.辅助配体手性和菲咯啉官能团取代对铂(II)基金属嵌入剂细胞毒性的影响。
J Inorg Biochem. 2007 Jul;101(7):1049-58. doi: 10.1016/j.jinorgbio.2007.04.009. Epub 2007 May 4.
3
Model platinum nucleobase and nucleoside complexes and antitumor activity: X-ray crystal structure of [PtIV(trans-1R,2R-diaminocyclohexane)trans-(acetate)2(9-ethylguanine)Cl]NO3.H2O.铂核碱基和核苷配合物模型及其抗肿瘤活性:[PtIV(反式-1R,2R-二氨基环己烷)反式-(乙酸根)2(9-乙基鸟嘌呤)氯]硝酸盐水合物的X射线晶体结构
J Inorg Biochem. 2005 Mar;99(3):795-804. doi: 10.1016/j.jinorgbio.2004.12.015.
4
Characterization of chemosensitivity and resistance of human cancer cell lines to platinum(II) versus platinum(IV) anticancer agents.人类癌细胞系对铂(II)与铂(IV)抗癌药物的化学敏感性和耐药性特征分析。
Anticancer Drugs. 2009 Aug;20(7):559-72. doi: 10.1097/CAD.0b013e32832d513b.
5
Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.轴向和赤道配体对反式-1R,2R-二氨基环己烷铂(IV)配合物抗肿瘤活性的调节作用。
Anticancer Drug Des. 1994 Apr;9(2):139-51.
6
Modulation of cytotoxicity and cellular pharmacology of 1,2-diaminocyclohexane platinum (IV) complexes mediated by axial and equatorial ligands.轴向和赤道配体介导的1,2-二氨基环己烷铂(IV)配合物的细胞毒性和细胞药理学调节
Cancer Res. 1993 Oct 1;53(19):4567-72.
7
X-ray structure and circular dichroism of pure rotamers of bis[guanosine-5'-monophosphate(-1)](N,N,N',N'-tetramethylcyclohexyl-1,2-diamine)platinum(II) complexes that have R,R and S,S configurations at the asymmetric diamine.在不对称二胺处具有R,R和S,S构型的双[鸟苷-5'-单磷酸(-1)](N,N,N',N'-四甲基环己基-1,2-二胺)铂(II)配合物的纯旋转异构体的X射线结构和圆二色性
Chemistry. 2003 Dec 15;9(24):6122-32. doi: 10.1002/chem.200305152.
8
DNA binding and biological activity of some platinum(II) intercalating compounds containing methyl-substituted 1,10-phenanthrolines.一些含有甲基取代的1,10-菲咯啉的铂(II)插入化合物的DNA结合及生物活性
Dalton Trans. 2004 Apr 21(8):1145-52. doi: 10.1039/b316511f. Epub 2004 Mar 19.
9
New isomeric azine-bridged dinuclear platinum(II) complexes circumvent cross-resistance to cisplatin.新型异构体嗪桥联双核铂(II)配合物可规避对顺铂的交叉耐药性。
J Med Chem. 2003 Mar 27;46(7):1210-9. doi: 10.1021/jm020004+.
10
Preparation, DNA binding, and in vitro cytotoxicity of a pair of enantiomeric platinum(II) complexes, [(R)- and (S)-3-aminohexahydroazepine]dichloroplatinum(II). Crystal structure of the S enantiomer.一对对映体铂(II)配合物[(R)-和(S)-3-氨基六氢氮杂卓]二氯铂(II)的制备、DNA结合及体外细胞毒性。S对映体的晶体结构。
J Med Chem. 1997 Mar 28;40(7):1090-8. doi: 10.1021/jm9607966.

引用本文的文献

1
Platinum(IV) Prodrugs Incorporating an Indole-Based Derivative, 5-Benzyloxyindole-3-Acetic Acid in the Axial Position Exhibit Prominent Anticancer Activity.轴向位置含有吲哚基衍生物 5-苯甲氧基吲哚-3-乙酸的铂(IV)前药表现出显著的抗癌活性。
Int J Mol Sci. 2024 Feb 11;25(4):2181. doi: 10.3390/ijms25042181.
2
Synthesis and Characterisation of Fluorescent Novel Pt(II) Cyclometallated Complexes with Anticancer Activity.新型具有抗癌活性的荧光 Pt(II) 金属环配合物的合成与表征。
Int J Mol Sci. 2023 Apr 28;24(9):8049. doi: 10.3390/ijms24098049.
3
Versatile Platinum(IV) Prodrugs of Naproxen and Acemetacin as Chemo-Anti-Inflammatory Agents.
萘普生和阿西美辛的多功能铂(IV)前药作为化学抗炎剂
Cancers (Basel). 2023 Apr 26;15(9):2460. doi: 10.3390/cancers15092460.
4
Bioactive Platinum(IV) Complexes Incorporating Halogenated Phenylacetates.含卤素苯乙酸的生物活性铂(IV)配合物。
Molecules. 2022 Oct 21;27(20):7120. doi: 10.3390/molecules27207120.
5
Potent Chlorambucil-Platinum(IV) Prodrugs.强效氯氨铂(IV)前药。
Int J Mol Sci. 2022 Sep 9;23(18):10471. doi: 10.3390/ijms231810471.
6
Manipulating exciton dynamics of thermally activated delayed fluorescence materials for tuning two-photon nanotheranostics.调控热激活延迟荧光材料的激子动力学以优化双光子纳米诊疗技术。
Chem Sci. 2019 Dec 11;11(3):888-895. doi: 10.1039/c9sc05817f.
7
Use of Half-Generation PAMAM Dendrimers (G0.5-G3.5) with Carboxylate End-Groups to Improve the DACHPtCl and 5-FU Efficacy as Anticancer Drugs.使用带羧酸盐端基的半代 PAMAM 树状大分子(G0.5-G3.5)提高 DACHPtCl 和 5-FU 的疗效作为抗癌药物。
Molecules. 2021 May 14;26(10):2924. doi: 10.3390/molecules26102924.
8
A Systems Biology Approach to Understanding the Mechanisms of Action of an Alternative Anticancer Compound in Comparison to Cisplatin.一种系统生物学方法,用于理解一种替代抗癌化合物与顺铂相比的作用机制。
Proteomes. 2014 Nov 10;2(4):501-526. doi: 10.3390/proteomes2040501.
9
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs.下一代铂类药物:靶向铂(II)剂、纳米颗粒递送及铂(IV)前药
Chem Rev. 2016 Mar 9;116(5):3436-86. doi: 10.1021/acs.chemrev.5b00597. Epub 2016 Feb 11.
10
A dual-targeting, p53-independent, apoptosis-inducing platinum(II) anticancer complex, [Pt(BDI(QQ))]Cl.一种双靶向、不依赖p53、诱导凋亡的铂(II)抗癌配合物,[Pt(BDI(QQ))]Cl。
Metallomics. 2014 Mar;6(3):437-43. doi: 10.1039/c3mt00364g. Epub 2014 Feb 11.